Cargando…
Cardiac Adverse Events With Remdesivir in COVID-19 Infection
Since December 2019, coronavirus has gradually progressed to a pandemic with no efficacious treatment. Remdesivir is an antiviral medication and inhibitor of viral RNA dependent RNA polymerase with inhibitory action against SARS-CoV virus. Two patients diagnosed with coronavirus infection with worse...
Autores principales: | Gupta, Anupam K, Parker, Barbara M, Priyadarshi, Vikash, Parker, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682945/ https://www.ncbi.nlm.nih.gov/pubmed/33240723 http://dx.doi.org/10.7759/cureus.11132 |
Ejemplares similares
-
Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19
por: Wasef, Natale, et al.
Publicado: (2022) -
Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?
por: Maheshwari, Mani, et al.
Publicado: (2021) -
Cardiac Adverse Reactions With COVID-19 Vaccinations
por: De Jesus, Mikhail L, et al.
Publicado: (2022) -
MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running
por: Abrahim, Mohammed
Publicado: (2022) -
Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review
por: Abdelmaseih, Ramy, et al.
Publicado: (2020)